Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to $33.0 million.

  • CureVac's Net Cash Flow fell 9139.04% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$138.5 million, marking a year-over-year decrease of 23489.36%. This contributed to the annual value of $83.7 million for FY2024, which is 18434.23% up from last year.
  • According to the latest figures from Q3 2025, CureVac's Net Cash Flow is $33.0 million, which was down 9139.04% from -$50.9 million recorded in Q2 2025.
  • CureVac's 5-year Net Cash Flow high stood at $302.4 billion for Q4 2021, and its period low was -$348.0 billion during Q3 2021.
  • Over the past 5 years, CureVac's median Net Cash Flow value was -$45.4 million (recorded in 2025), while the average stood at -$953.6 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 5766714.22% in 2021, then tumbled by 8411308.11% in 2022.
  • CureVac's Net Cash Flow (Quarter) stood at $302.4 billion in 2021, then plummeted by 100.01% to -$37.5 million in 2022, then crashed by 70.63% to -$63.9 million in 2023, then decreased by 17.68% to -$75.2 million in 2024, then surged by 143.89% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q3 2025, -$50.9 million for Q2 2025, and -$45.4 million during Q1 2025.